31/01/2026
🇱🇹 In 2025, Lithuania ranked among the TOP EU countries for life-sciences export intensity — yet most HealthTech startups here still fail to convert pilots into cross-border revenue.
That gap is not about talent or technology.
It’s about export-readiness by design.
Lithuania has:
• export-grade diagnostics and CDMOs
• EU-connected health data infrastructure
• strong clinical validation capacity
Yet many founders still build local pilots that die locally.
So I mapped what actually scales from Lithuania into the EU 👇
🇱🇹 The Lithuania HealthTech Export Stack (what converts, not what demos)
1️⃣ Lab Diagnostics: Where credibility is created
- Lithuania’s unfair advantage is QA-ready validation, not “early pilots”.
- Northway Biotech · Thermo Fisher (Vilnius) · Biomapas · Biotechpharma · Santaros Klinikos labs · LSMU · Vilnius University Life Sciences Center · Eurofins · SYNLAB
- Action: Design pilots that survive regulatory + buyer scrutiny, not just clinical interest.
2️⃣ Data Infrastructure: Where scale usually breaks
- Lithuania is already wired into EU health data rails — most startups just ignore them.
- eSveikata · HL7 Lithuania · openEHR · SNOMED · LOINC · MyHealth@EU · InterSystems IRIS · SAP Health Data Services
- Action: If you’re not FHIR-ready from day one, expansion will cost you 6–12 months later.
3️⃣ Care Platforms: Where revenue actually shows up
- This is where Lithuania-based companies prove monetization, not just adoption.
- Kilo Health · TeltoHeart (Teltonika) · Doctolib · Kry/Livi · Doctorly · Ada · Infermedica · Huma · Luscii · Current Health
- Action: Anchor to a buyer rail (employer, provider group, payer) — not just users.
4️⃣ Scale Enablers: Where contracts are unlocked
- quietly excels here — founders just don’t sequence it correctly.
- · Startup Lithuania · LithuaniaBIO · Lab · Tech Park · STP · EIT Health · Startup Wise Guys · Baltic Sandbox Ventures
- Action: Use these as go-to-market accelerators, not pitch-deck logos.